NASDAQ · IINN
Inspira Technologies OXY B.H.N. Ltd.
$1.05-$0.01 (-0.94%)
Inspira Technologies OXY B.H.N. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
Loading market information…
NASDAQ · SINT · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Sintx Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Sintx Technologies, Inc.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of -$0.31. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sintx Technologies, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 15, 2025 | -$1.29-70.86% vs estimate | $400.00K-44.83% vs estimate |
|---|
| Q4 2024 | Mar 19, 2025 | -$1.26+10.0% vs estimate | $500.00K-7.75% vs estimate |
|---|
| Q3 2024 | Nov 12, 2024 | -$6.95+3.47% vs estimate | $799.00K+14.14% vs estimate |
|---|
THE ANALYST VIEW
3 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.05-$0.01 (-0.94%)
Inspira Technologies OXY B.H.N. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$3.61+$0.24 (+7.12%)
HeartSciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.2% below the high.
$5.91+$0.16 (+2.78%)
Lifeward Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.5% below the high.
$0.28-$0.02 (-5.73%)
Pheton Holdings Ltd Class A Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 99.12% below the high.
$0.77+$0.01 (+0.69%)
Profusa, Inc. Common Stock’s quoted price sits in the lower half of its reported 52-week range, 99.96% below the high.
$1.73-$0.01 (-0.57%)
TransCode Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.27% below the high.
$2.31-$0.05 (-2.12%)
Beyond Air, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.66% below the high.
$2.29+$0.03 (+1.33%)
Tenon Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.97% below the high.
